Stay updated on TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial

Sign up to get notified when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, indicating a platform or display update rather than a change to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-26T15:34:12.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision history updated: added Revision v3.5.2 and removed Revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T13:55:20.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision history now shows a new v3.5.0 release. It removes the previous v3.4.3 entry.
    Difference
    0.1%
    Check dated 2026-03-21T20:15:28.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T08:48:04.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the history and the prior revision v3.4.1 was removed.
    Difference
    0.1%
    Check dated 2026-02-13T18:14:49.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry v3.4.1 was added to the history, and the previous revision v3.4.0 was removed.
    Difference
    0.1%
    Check dated 2026-02-06T11:34:23.000Z thumbnail image

Stay in the know with updates to TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAK-330 for Direct Oral Factor Xa Anticoagulation Reversal Clinical Trial page.